These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3496099)

  • 1. Inhibition of cytochrome P-450-dependent oxidation reactions by MAO inhibitors in rat liver microsomes.
    Dupont H; Davies DS; Strolin-Benedetti M
    Biochem Pharmacol; 1987 May; 36(10):1651-7. PubMed ID: 3496099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic evidence for heterogeneous responsiveness of mixed function oxidase isozymes to inhibition and induction by allylisopropylacetamide in chick embryo liver.
    Rifkind AB; Troeger M; Muschick H
    J Biol Chem; 1982 Oct; 257(19):11717-27. PubMed ID: 6981647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aniline hydroxylation and 7-ethoxycoumarin O-deethylation activities in solubilized and partially resolved liver cytochromes P-450 from ethanol-fed rats.
    Plourde V; Hétu C; Joly JG
    Can J Physiol Pharmacol; 1984 Mar; 62(3):266-71. PubMed ID: 6609756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (+)-bufuralol 1'-hydroxylation activity in human and rhesus monkey intestine and liver.
    Prueksaritanont T; Dwyer LM; Cribb AE
    Biochem Pharmacol; 1995 Oct; 50(9):1521-5. PubMed ID: 7503805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of quinidine and quinine on liver microsome oxidation enzymes in man and rat.
    Tu ZG; Zhao LL
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):541-4. PubMed ID: 9863152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic acetone administration on ethanol-inducible monooxygenase activities in the rat.
    Hétu C; Joly JG
    Biochem Pharmacol; 1988 Feb; 37(3):421-6. PubMed ID: 3122762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of cyanide on the activities of 7-ethoxycoumarin O-deethylation catalyzed by two forms of cytochrome P-450 purified from 3-methylcholanthrene-treated rats.
    Kitada M; Sakamoto K; Rikihisa T; Kanakubo Y
    Biochem Pharmacol; 1985 Apr; 34(8):1133-6. PubMed ID: 3922372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-Ethoxycoumarin dealkylase and cytochrome P-450 from grey partridge (Perdix perdix) hepatic and duodenal microsomes.
    Rivière JL
    Biochem Biophys Res Commun; 1980 Nov; 97(2):546-52. PubMed ID: 6781496
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism-based in vivo inactivation of lauric acid hydroxylases.
    CaJacob CA; Ortiz de Montellano PR
    Biochemistry; 1986 Aug; 25(16):4705-11. PubMed ID: 3490272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new monooxygenase product from 7-ethoxycoumarin and its relation to the O-dealkylation reaction.
    Jung B; Graf H; Ullrich V
    Biol Chem Hoppe Seyler; 1985 Jan; 366(1):23-31. PubMed ID: 3873950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cytochrome P-450-dependent mixed function oxidation by ethanol.
    Hayashi N; Kamada T; Sato N; Kasahara A; Peterson JA
    Dig Dis Sci; 1985 Apr; 30(4):334-9. PubMed ID: 2983957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human liver cytochrome P-450 by omeprazole.
    Jensen JC; Gugler R
    Br J Clin Pharmacol; 1986 Mar; 21(3):328-30. PubMed ID: 3485990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene B4 omega-hydroxylase in rat liver microsomes: identification as a cytochrome P-450 that catalyzes prostaglandin A1 omega-hydroxylation, and participation of cytochrome b5.
    Sumimoto H; Kusunose E; Gotoh Y; Kusunose M; Minakami S
    J Biochem; 1990 Aug; 108(2):215-21. PubMed ID: 2172223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P-450 and ethoxycoumarin-deethylation in rat gastric microsomes: induction by 3-methylcholanthrene and inhibition by cimetidine.
    Borm P; Bast A; Frankhuijzen-Sierevogel A; Noordhoek J
    Biochem Biophys Res Commun; 1981 Sep; 102(2):784-90. PubMed ID: 6975627
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA; Tjia JF; Back DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of drug oxidation by anhydroerythromycin, an acid degradation product of erythromycin.
    Stupans I; Sansom LN
    Biochem Pharmacol; 1991 Nov; 42(11):2085-90. PubMed ID: 1958226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
    Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT
    Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies inhibitory to rat hepatic cytochromes P-450: P-450 form specificities and use as probes for cytochrome P-450-dependent steroid hydroxylations.
    Waxman DJ; Lapenson DP; Park SS; Attisano C; Gelboin HV
    Mol Pharmacol; 1987 Nov; 32(5):615-24. PubMed ID: 3119986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver.
    Oetari S; Sudibyo M; Commandeur JN; Samhoedi R; Vermeulen NP
    Biochem Pharmacol; 1996 Jan; 51(1):39-45. PubMed ID: 8534266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.